
Francis S. Collins
@NIHDirector
In preclinical research, the investigational anticancer drug plitidepsin shows potent antiviral activity against #COVID19, suggesting the need for further evaluation of this drug for this use. Read more: http://bit.ly/36v6P5I@NIAIDNews
@NIMHgov
#NIH
Traducir Tweet
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
SARS-CoV-2 viral proteins interact with the eukaryotic translation machinery and inhibitors of translation have potent antiviral effects. Here we report that the drug plitidepsin (aplidin), which has...
science.sciencemag.org
9:32 p. m. · 5 feb. 2021·Twitter Web App